The local media focuses on epilepsy, since that community lead the charge for cannabidiol in Kentucky, but the new law actually does not limit by condition. It merely declassifies cannabidiol from the definition of marijuana and allows doctors affiliated with The University of Kentucky and The University of Louisville to prescribe high CBD products or use them in clinical trials. Even though no product is available yet in Kentucky, it can't hurt to start those conversations with doctors now so that ground is already covered by the time CBD Oil arrives.
Since I am currently being treated for breast cancer, I want to bring all the animal model research on cannabidiol and that condition to my doctor at James Graham Brown Cancer Center. I needed a place to store those links, so I decided to create a post on this blog for them, even though this is an autism and epilepsy website. Later I will add links for other forms of cancer so patients interested in bringing research to their own doctors can print them. At a later date I may make a separate website for CBD and cancer, but right now I'm busy with autism and epilepsy.
Cannabidiol and Breast Cancer Links
Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
Breast Cancer Res Treat. 2012 May;133(1):401-4.
Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells.Mol Cancer Ther. 2007 Nov;6(11):2921-7.
PLoS One. 2011;6(9):e23901. d oi: 10.1371/journal.pone.0023901. Epub 2011 Sep 7.
Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion.
Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinomaAmerican Society for Pharmacology and Experimental Therapeutics
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibitionMolecular Cancer 2010, 9:196
Cannabinoids: a new hope for breast cancer therapy?
Cancer Treat Rev. 2012 Nov;38(7):911-8.
The endogenous cannabinoid anandamide inhibits human breastcancer cell proliferationProc. Natl. Acad. Sci. USAVol. 95, pp. 8375–8380, July 1998
Cannabis Compound May Stop Metastatic Breast Cancer - ABC News
Animal Model Studies on Cannabidiol and Protection From Chemo Side Effects
Cannabidiol Inhibits Paclitaxel Neuropathic Pain Through 5-HT(1A) Receptors Without Diminishing Nervous System Functioning or Chemo Efficacy
British Journal of Pharmacology, February 14, 2014
Cardioprotective Effect of Rats Exposed to Doxorubicin Toxicity
Environmental Toxicology, September 2013
